Toshiaki Aoki

930 total citations
22 papers, 783 citations indexed

About

Toshiaki Aoki is a scholar working on Organic Chemistry, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Toshiaki Aoki has authored 22 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Molecular Biology and 6 papers in Molecular Medicine. Recurrent topics in Toshiaki Aoki's work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Toshiaki Aoki is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Toshiaki Aoki collaborates with scholars based in Japan, United States and Switzerland. Toshiaki Aoki's co-authors include Eng H. Lo, Xiaoying Wang, Tatsuro Mori, Paul L. Huang, Ken Arai, Dmitriy N. Atochin, Sun-Ryung Lee, Joan Montaner, Kiyoshi Tsuji and Emiri Tejima and has published in prestigious journals such as Angewandte Chemie International Edition, Stroke and Journal of Medicinal Chemistry.

In The Last Decade

Toshiaki Aoki

21 papers receiving 765 citations

Peers

Toshiaki Aoki

EPIDE

PHARM

Zhiqiang Zheng China

Reena Halai Australia

Sarika Gupta India

Roberta Ferraresi Italy

Giorgina Mangano Italy

Ornella Moltedo Italy

Naoki Sakura Japan

Manoj Paul India

Peihua Lu Canada

T. Mizushima Japan

Zhiqiang Zheng China

Toshiaki Aoki

569 ×1.9

109 ×0.5

EPIDE

39 ×0.3

PHARM

42 ×0.3

45 ×0.4

Citations per year, relative to Toshiaki Aoki Toshiaki Aoki (= 1×) peers Zhiqiang Zheng

Countries citing papers authored by Toshiaki Aoki

Since Specialization

Citations

This map shows the geographic impact of Toshiaki Aoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Aoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Aoki more than expected).

Fields of papers citing papers by Toshiaki Aoki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Aoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Aoki. The network helps show where Toshiaki Aoki may publish in the future.

Co-authorship network of co-authors of Toshiaki Aoki

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Aoki. A scholar is included among the top collaborators of Toshiaki Aoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Aoki. Toshiaki Aoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kusano, Hiroki, Toshiaki Aoki, Takuya Oguma, et al.. (2022). Discovery of a Tricyclic β-Lactam as a Potent Antimicrobial Agent against Carbapenem-Resistant Enterobacterales, Including Strains with Reduced Membrane Permeability and Four-Amino Acid Insertion into Penicillin-Binding Protein 3: Structure–Activity-Relationships and In Vitro and In Vivo Activities. ACS Infectious Diseases. 8(3). 400–410. 7 indexed citations

Kusano, Hiroki, Toshiaki Aoki, Takuya Oguma, et al.. (2021). A novel tricyclic β-lactam exhibiting potent antibacterial activities against carbapenem-resistant Enterobacterales: Synthesis and structure-activity-relationships. Bioorganic & Medicinal Chemistry. 46. 116343–116343. 10 indexed citations

Kusano, Hiroki, Soichiro Sato, Toshiaki Aoki, et al.. (2021). Discovery of 2-Sulfinyl-Diazabicyclooctane Derivatives, Potential Oral β-Lactamase Inhibitors for Infections Caused by Serine β-Lactamase-Producing Enterobacterales. Journal of Medicinal Chemistry. 64(13). 9496–9512. 8 indexed citations

Kusano, Hiroki, et al.. (2020). Introduction of a Thio Functional Group to Diazabicyclooctane: An Effective Modification to Potentiate the Activity of β-Lactams against Gram-Negative Bacteria Producing Class A, C, and D Serine β-Lactamases. ACS Infectious Diseases. 6(11). 3034–3047. 4 indexed citations

Aoki, Toshiaki, et al.. (2020). Synthesis of 2-Thio-Substituted 1,6-Diazabicyclo[3.2.1]octane Derivatives, Potent β-Lactamase Inhibitors. The Journal of Organic Chemistry. 85(15). 9650–9660. 13 indexed citations

Aoki, Toshiaki, Hidenori Yoshizawa, Kenji Yamawaki, et al.. (2018). Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship. European Journal of Medicinal Chemistry. 155. 847–868. 133 indexed citations

Murai, Nobuhito, Hideki Hiyama, Tetsuo Kiso, et al.. (2017). Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents. Neuropharmacology. 126. 97–107. 35 indexed citations

Suzuki, Hideyuki, et al.. (2013). Potent Oxazolidinone Antibacterials with Heteroaromatic C-Ring Substructure. ACS Medicinal Chemistry Letters. 4(11). 1074–1078. 22 indexed citations

Ozeki, Yutaka, Isamu Sugawara, Tadashi Udagawa, et al.. (2010). Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice. International Immunology. 22(3). 179–189. 28 indexed citations

10.

Aoki, Toshiaki, Kouji Kuramochi, Toshifumi Takeuchi, et al.. (2010). Synthesis and Neuroprotective Action of Optically Pure Neoechinulin A and Its Analogs. Pharmaceuticals. 3(4). 1063–1069. 7 indexed citations

11.

Kobayashi, Susumu, Kouji Kuramochi, Toshiaki Aoki, et al.. (2008). Synthesis of Neoechinulin A and Derivatives. Synthesis. 2008(23). 3810–3818. 17 indexed citations

12.

Aoki, Toshiaki, Yasushi Shibata, Shinji Kamisuki, et al.. (2007). Structure-activity Relationships of Neoechinulin A Analogues with Cytoprotection against Peroxynitrite-induced PC12 Cell Death. The Journal of Antibiotics. 60(10). 614–621. 35 indexed citations

13.

Aoki, Toshiaki, Shinji Kamisuki, Yoichi Takakusagi, et al.. (2006). Total Synthesis of (-)-Neoechinulin A. Synlett. 677–680. 5 indexed citations

14.

Tsuji, Kiyoshi, Toshiaki Aoki, Emiri Tejima, et al.. (2005). Tissue Plasminogen Activator Promotes Matrix Metalloproteinase-9 Upregulation After Focal Cerebral Ischemia. Stroke. 36(9). 1954–1959. 190 indexed citations

15.

Aoki, Toshiaki, et al.. (2004). Highly Efficient Total Synthesis of (+)‐Citreoviral. Angewandte Chemie International Edition. 43(24). 3175–3177. 23 indexed citations

16.

Aoki, Toshiaki, et al.. (2004). Highly Efficient Total Synthesis of (+)‐Citreoviral. Angewandte Chemie. 116(24). 3237–3239. 2 indexed citations

17.

Mori, Tatsuro, Xiaoying Wang, Toshiaki Aoki, & Eng H. Lo. (2002). Downregulation of Matrix Metalloproteinase-9 and Attenuation of Edema via Inhibition of ERK Mitogen Activated Protein Kinase in Traumatic Brain Injury. Journal of Neurotrauma. 19(11). 1411–1419. 114 indexed citations

18.

Saitoh, Masato, et al.. (2001). [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture].. PubMed. 54(2). 79–87. 12 indexed citations

19.

Sugawara, Isamu, Hiroyuki Yamada, Yuko Kazumi, et al.. (1998). Induction of granulomas in interferon- gene-disrupted mice by avirulent but not by virulent strains of Mycobacterium tuberculosis. Journal of Medical Microbiology. 47(10). 871–877. 46 indexed citations

20.

Yoshioka, Hiroshi, Toshiaki Aoki, Kazumi Nakatsu, et al.. (1971). Chemical studies on tuberactinomycin. II. The structure of tuberactinomycin 0. Tetrahedron Letters. 12(23). 2043–2046. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact